Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E, Graham MJ, Mullick AE, Miller ER, Crooke RM, Pitas RE, Witztum JL, Tsimikas S. Merki E, et al. Among authors: miller er. Circulation. 2008 Aug 12;118(7):743-53. doi: 10.1161/CIRCULATIONAHA.108.786822. Epub 2008 Jul 28. Circulation. 2008. PMID: 18663084
Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH. Tsimikas S, et al. Among authors: miller er. Circulation. 2004 Jun 29;109(25):3164-70. doi: 10.1161/01.CIR.0000130844.01174.55. Epub 2004 Jun 7. Circulation. 2004. PMID: 15184281
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Tsimikas S, et al. Among authors: miller er. Circulation. 2004 Sep 14;110(11):1406-12. doi: 10.1161/01.CIR.0000141728.23033.B5. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353498 Clinical Trial.
High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.
Schneider M, Witztum JL, Young SG, Ludwig EH, Miller ER, Tsimikas S, Curtiss LK, Marcovina SM, Taylor JM, Lawn RM, Innerarity TL, Pitas RE. Schneider M, et al. Among authors: miller er. J Lipid Res. 2005 Apr;46(4):769-78. doi: 10.1194/jlr.M400467-JLR200. Epub 2005 Jan 16. J Lipid Res. 2005. PMID: 15654123 Free article.
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Tsimikas S, et al. Among authors: miller er. N Engl J Med. 2005 Jul 7;353(1):46-57. doi: 10.1056/NEJMoa043175. N Engl J Med. 2005. PMID: 16000355 Free article.
Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S, Aikawa M, Miller FJ Jr, Miller ER, Torzewski M, Lentz SR, Bergmark C, Heistad DD, Libby P, Witztum JL. Tsimikas S, et al. Among authors: miller er, miller fj jr. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):175-81. doi: 10.1161/01.ATV.0000251501.86410.03. Epub 2006 Nov 2. Arterioscler Thromb Vasc Biol. 2007. PMID: 17082490
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
Tsimikas S, Clopton P, Brilakis ES, Marcovina SM, Khera A, Miller ER, de Lemos JA, Witztum JL. Tsimikas S, et al. Among authors: miller er. Circulation. 2009 Apr 7;119(13):1711-9. doi: 10.1161/CIRCULATIONAHA.108.836940. Epub 2009 Mar 23. Circulation. 2009. PMID: 19307470 Free PMC article.
Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL. Tsimikas S, et al. Among authors: miller er. J Am Coll Cardiol. 2006 Jun 6;47(11):2219-28. doi: 10.1016/j.jacc.2006.03.001. Epub 2006 May 15. J Am Coll Cardiol. 2006. PMID: 16750687 Free article.
683 results